Mylan Labs Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN LABS LTD, and what generic and branded alternatives to MYLAN LABS LTD drugs are available?
MYLAN LABS LTD has seventy-one approved drugs.
There are nine tentative approvals on MYLAN LABS LTD drugs.
Drugs and US Patents for Mylan Labs Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Labs Ltd | SULFAMETHOXAZOLE AND TRIMETHOPRIM | sulfamethoxazole; trimethoprim | INJECTABLE;INJECTION | 206607-001 | Aug 30, 2017 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Labs Ltd | FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | fluconazole | INJECTABLE;INJECTION | 076889-002 | Mar 25, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Mylan Labs Ltd | LINEZOLID | linezolid | SOLUTION;INTRAVENOUS | 205154-001 | Dec 6, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Labs Ltd | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | POWDER;INTRAVENOUS | 209481-001 | Jul 10, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Mylan Labs Ltd | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 205242-001 | Dec 6, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Labs Ltd | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 203852-001 | Nov 30, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.